-
Akanda's CEO On Paid Leave Of Absence
Thursday, December 22, 2022 - 12:22pm | 435Akanda Corp. (NASDAQ: AKAN) announced that CEO Tej Virk has been on a paid leave of absence both administrative and personal since November 30, 2022, pending an independent investigation being conducted by Canmart Directors and counsel. During his leave, Virk is not expected to perform any...
-
Akanda Partners With Berner's Cookies To Bring The Cannabis Brand And Its High THC Strains To Portugal
Tuesday, September 13, 2022 - 8:41am | 559International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) signed an exclusive license agreement with international cannabis lifestyle brand Cookies. Under the terms of the license agreement, Akanda gains the ability to cultivate, manufacture and distribute Cookies strains, and the...
-
Aurora Cannabis & Other Market Operators Just Made Some Key Executive Changes You Should Know About
Friday, September 9, 2022 - 8:07am | 1157Top CEOs, investors and leaders in the cannabis industry will soon convene at the Benzinga Cannabis Capital Conference on Sept. 13-14 in Chicago. In the meantime, let's scroll through the latest leadership changes within the space. Aurora’s Terry Booth Joins Akanda’s Advisory...
-
Akanda Strengthens Overseas Presence By Becoming Supplier For European Medical Cannabis Company
Tuesday, August 9, 2022 - 11:18am | 423International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) has signed a multi-year supply agreement with European medical cannabis company Cansativa GmbH to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen. Under the agreement...
-
Akanda To Contest Unauthorized Liquidation Of Its Subsidiary, Bophelo Bio Science & Wellness
Wednesday, July 27, 2022 - 8:23am | 572Akanda Corp. (NASDAQ: AKAN) revealed that the High Court of Lesotho has placed in liquidation the company’s indirect, wholly-owned subsidiary, Bophelo Bio Science & Wellness Ltd. The action to place Bophelo in liquidation was taken by the Lesotho Court pursuant to an unauthorized...
-
Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug
Tuesday, July 12, 2022 - 9:15am | 634Akanda Corp. (NASDAQ: AKAN) will supply Tetra Bio-Pharma (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) with pharmaceutical grade cannabis flower in a microdose cap form, for use in a Storz & Bickel Mighty Medic Vaporizer for global commercialization of Tetra’s QIXLEEF and related products. In...
-
Akanda's CanMart Partners With Phlo Connect And Cellen Life Sciences To Strengthen Its Position In UK Medical Cannabis Market
Tuesday, June 28, 2022 - 11:26am | 463CanMart Ltd. wholly-owned subsidiary of Akanda Corp. (NASDAQ: AKAN) has partnered with Phlo Connect and Cellen Life Sciences to create a fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens CanMart’s existing partnership with Cellen’s...
-
Akanda Shareholders Take Matters Into Their Hands - Replace A Majority Of Directors
Thursday, June 23, 2022 - 11:14am | 861Concerned shareholders of Akanda Corp. (NASDAQ: AKAN) have replaced a majority of the board of directors of the corporation, with highly-qualified and motivated directors. The concerned shareholders of the corporation collectively own or control approximately 54.1% of the issued and outstanding...
-
Akanda Completes Acquisition Of Holigen, Strengthening Position In EMEA Region
Monday, May 2, 2022 - 8:22am | 339Akanda Corp. (NASDAQ: AKAN) has closed the acquisition of Holigen Limited from The Flowr Corporation (TSXV:FLWR) (OTCPK:FLWPF), accelerating Akanda’s seed-to-patient business model in the EMEA region, improving the company’s ability to meet growing demand for medical cannabis and...
-
Akanda Corp's Cannabis Shares Soar In Nasdaq Debut Then Level Off
Tuesday, March 15, 2022 - 7:14pm | 371Akanda Corp.'s (NASDAQ:AKAN) shares soared shortly after the company's Nasdaq trading debut on Tuesday, less than a year after the cannabis company was formed. The London-based Akanda priced 4 million common shares at $4 per share for proceeds of $16 million in a...
-
Akanda Corp. Announces Pricing Of IPO, Set To Commence Trading On NASDAQ
Monday, March 14, 2022 - 8:54pm | 319Akanda Corp (NASDAQ: AKAN) an international medical cannabis company, announced the pricing of its initial public offering of 4 million common shares at $4.00 per share to the public for a total of $16 million in gross proceeds to the Company, prior to deducting...
-
Cannabis Movers & Shakers: Cresco, Agricor & Botanacor, C3 Industries, Akanda, CULTA, OWP, Zynerba
Thursday, February 17, 2022 - 11:32am | 1381Cresco Labs Taps Megan Kulick To Serve As VP Of Investor Relations Cresco Labs (OTC: CRLBF) appointed Megan Kulick to the role of senior vice president of investor relations. Kulick has over 20 years of experience in investor relations, equity research, and portfolio management at bulge...
-
Akanda Names Dr. Sunny Nayee U.K. Medical Director To Support Partnership With Cellen
Wednesday, February 16, 2022 - 10:43am | 379International medical cannabis company Akanda Corp. named Dr. Sunny Nayee as its new UK medical director. The appointment of Nayee, a pain treatment expert with direct experience in cannabis therapies, builds upon the company’s partnership with Cellen Life Sciences. At Akanda, Nayee will be...
-
Akanda Wraps Up $5M Private Placement, Will Distribute Cannim Cannabis Products Across UK Via CanMart
Wednesday, November 17, 2021 - 12:26pm | 502Akanda Corp. announced on Wednesday that it has secured $5.31 million in financing through a private placement of its securities. The London-based company closed the transaction and plans to use the net proceeds for working capital and general corporate purposes. Tej Virk, Akanda’s CEO and...
-
Cannabis Movers & Shakers: Tyson 2.0, Akanda, Shryne Group, MedMen
Friday, November 12, 2021 - 4:45pm | 1106Akanda Taps Dr. Aslihan Akkar-Schenkl As President Akanda Corp., which recently spun off from Halo Collective Inc. (NEO: HALO) and now operates as an international medical cannabis company, announced Wednesday that Dr. Aslihan Akkar-Schenkl has joined its management team as president....